当前位置:首页 - 行情中心 - 可孚医疗(301087) - 财务分析

可孚医疗

(301087)

  

流通市值:87.08亿  总市值:93.65亿
流通股本:1.94亿   总股本:2.09亿

可孚医疗(301087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.60亿元,每股收益1.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益475049.30万元,未分配利润65835.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产654029.23万元,负债178979.94万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,397,791,920.731,495,764,000.12737,792,254.372,982,931,130.48
营业总成本2,140,937,840.581,324,393,499.85646,327,861.692,630,658,146.25
其他经营收益
营业利润301,810,929.65197,076,115.25109,667,821.89373,304,098.44
利润总额304,177,103.13199,658,996.39109,426,701.27371,999,125.99
净利润259,507,645.73166,642,911.691,572,859.16312,343,553.61
每股收益
其他综合收益643,588.1---
综合收益总额260,151,233.83166,642,911.691,572,859.16312,343,553.61
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,894,095,362.253,764,999,620.853,913,564,439.073,925,489,622.21
非流动资产:
非流动资产合计2,646,196,983.252,583,062,050.132,504,769,103.772,497,177,089.86
资产总计6,540,292,345.56,348,061,670.986,418,333,542.846,422,666,712.07
流动负债:
流动负债合计1,637,988,672.11,419,124,954.681,355,621,458.831,361,721,170.48
非流动负债:
非流动负债合计151,810,702.44154,512,523.24153,996,075258,596,371.41
负债合计1,789,799,374.541,573,637,477.921,509,617,533.831,620,317,541.89
所有者权益(或股东权益):
归属于母公司股东权益合计4,713,657,384.444,737,676,805.624,893,677,663.774,796,596,352.25
股东权益合计4,750,492,970.964,774,424,193.064,908,716,009.014,802,349,170.18
负债和股东权益合计6,540,292,345.56,348,061,670.986,418,333,542.846,422,666,712.07
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,636,305,027.871,633,833,084.46791,876,819.33,198,834,015.24
经营活动现金流出小计2,046,313,639.681,282,399,646.74681,818,542.112,535,440,735.14
经营活动产生的现金流量净额589,991,388.19351,433,437.72110,058,277.19663,393,280.1
投资活动产生的现金流量:
投资活动现金流入小计1,311,720,780.841,191,807,578.5568,698,795.13940,587,658.17
投资活动现金流出小计1,477,933,054.821,145,094,643.56163,604,201.841,671,555,887.99
投资活动产生的现金流量净额-166,212,273.9846,712,934.99-94,905,406.71-730,968,229.82
筹资活动产生的现金流量:
筹资活动现金流入小计1,136,639,341.57597,133,829.84439,085,657.3807,387,199.48
筹资活动现金流出小计1,486,487,292.43992,524,915.49543,366,028.241,041,626,986.21
筹资活动产生的现金流量净额-349,847,950.86-395,391,085.65-104,280,370.94-234,239,786.73
汇率变动对现金及现金等价物的影响-2,049,743.68-543,325.85-1,034.91587,813.94
现金及现金等价物净增加额71,881,419.672,211,961.21-89,128,535.37-301,226,922.51
期末现金及现金等价物余额1,211,867,558.211,142,198,099.751,050,857,603.171,139,986,138.54
补充资料:
现金及现金等价物的净增加额-2,211,961.21--301,226,922.51
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
信达证券唐爱金,曹佳琳1.862.322.822025-10-30
东方财富证券何玮1.682.072.492025-08-31
华安证券李婵,谭国超1.982.412.932025-08-28
华源证券刘闯1.762.182.602025-08-28
信达证券唐爱金,曹佳琳1.862.312.822025-08-27
TOP↑